21.38Open21.38Pre Close0 Volume3 Open Interest60.00Strike Price0.00Turnover79.81%IV4.04%PremiumAug 16, 2024Expiry Date18.22Intrinsic Value100Multiplier24DDays to Expiry3.16Extrinsic Value100Contract SizeAmericanOptions Type0.9211Delta0.0092Gamma4.11Leverage Ratio-0.0562Theta0.0350Rho3.78Eff Leverage0.0296Vega
Skyline Stock Discussion
$Skyline(SKY.US)$ $Cavco Industries(CVCO.US)$ $Berkshire Hathaway-B(BRK.B.US)$
• $Allegiance(ABTX.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $Bunge(BG.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $Cerence(CRNC.US)$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $First Mid Bancshares(FMBH.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $Lamar Advertising Co(LAMR.US)$ : Citigroup Up...
• $SpringWorks Therapeutics(SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences(ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen(OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Skyline(SKY.US)$ +4.4% (In reaction to earnings)
• $NetEase(NTES.US)$ +4.1% (In...
No comment yet